New York State Common Retirement Fund’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$453K Hold
22,237
﹤0.01% 1934
2025
Q1
$404K Hold
22,237
﹤0.01% 1957
2024
Q4
$562K Hold
22,237
﹤0.01% 1904
2024
Q3
$756K Sell
22,237
-7,500
-25% -$255K ﹤0.01% 1772
2024
Q2
$1.1M Buy
29,737
+2,947
+11% +$109K ﹤0.01% 1718
2024
Q1
$1.12M Buy
26,790
+4,674
+21% +$196K ﹤0.01% 1721
2023
Q4
$877K Sell
22,116
-1,664
-7% -$66K ﹤0.01% 1847
2023
Q3
$654K Buy
23,780
+821
+4% +$22.6K ﹤0.01% 1948
2023
Q2
$779K Sell
22,959
-4,586
-17% -$156K ﹤0.01% 1897
2023
Q1
$991K Sell
27,545
-5,134
-16% -$185K ﹤0.01% 1873
2022
Q4
$1.46M Sell
32,679
-40
-0.1% -$1.78K ﹤0.01% 1798
2022
Q3
$920K Buy
32,719
+97
+0.3% +$2.73K ﹤0.01% 2023
2022
Q2
$879K Sell
32,622
-83
-0.3% -$2.24K ﹤0.01% 2085
2022
Q1
$1.11M Buy
32,705
+24
+0.1% +$817 ﹤0.01% 2057
2021
Q4
$1.26M Buy
32,681
+2,165
+7% +$83.7K ﹤0.01% 2017
2021
Q3
$1.65M Sell
30,516
-3,084
-9% -$167K ﹤0.01% 1860
2021
Q2
$1.12M Buy
+33,600
New +$1.12M ﹤0.01% 2168
2018
Q2
Sell
-7,553
Closed -$264K 3179
2018
Q1
$264K Hold
7,553
﹤0.01% 2625
2017
Q4
$322K Buy
7,553
+1,186
+19% +$50.6K ﹤0.01% 2550
2017
Q3
$273K Hold
6,367
﹤0.01% 2631
2017
Q2
$236K Sell
6,367
-1,433
-18% -$53.1K ﹤0.01% 2764
2017
Q1
$422K Hold
7,800
﹤0.01% 2462
2016
Q4
$414K Hold
7,800
﹤0.01% 2448
2016
Q3
$473K Hold
7,800
﹤0.01% 2336
2016
Q2
$514K Sell
7,800
-5,056
-39% -$333K ﹤0.01% 2270
2016
Q1
$729K Hold
12,856
﹤0.01% 2096
2015
Q4
$3.02M Sell
12,856
-1,478
-10% -$348K ﹤0.01% 1439
2015
Q3
$2.27M Buy
14,334
+717
+5% +$113K ﹤0.01% 1547
2015
Q2
$5.15M Buy
13,617
+1,797
+15% +$680K 0.01% 1335
2015
Q1
$4.94M Buy
11,820
+1,620
+16% +$677K 0.01% 1217
2014
Q4
$2.79M Buy
10,200
+1,613
+19% +$442K ﹤0.01% 1480
2014
Q3
$1.67M Hold
8,587
﹤0.01% 1697
2014
Q2
$2.1M Sell
8,587
-22,990
-73% -$5.63M ﹤0.01% 1645
2014
Q1
$8.37M Buy
31,577
+3,114
+11% +$825K 0.01% 1002
2013
Q4
$10.3M Buy
+28,463
New +$10.3M 0.02% 899